Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/stat6 pathway

Immunity

Volumn 11, Issue 4, 1999, Pages 463-472

  Homann, Dirk ^a   Holz, Andreas ^a   Bot, Adrian ^a   Coon, Bryan ^a   Wolfe, Tom ^a   Petersen, Jacob ^b   Dyrberg, Thomas P ^b   Grusby, Michael J ^c   Von Herrath, Matthias G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NOVO NORDISK A S   (Denmark)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; STAT6 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CYTOKINE RELEASE; DIABETES MELLITUS; HELPER CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033213471     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80121-1     Document Type: Article

References (50)

1. Akhtar, I., Gold, J.P., Pan, L.Y., Ferrara, J.L., Yang, X.D., Kim, J.I., and Tan, K.N. (1995). CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182, 87-97.
2. Al-Sabbagh, A., Miller, A., Santos, L.M., and Weiner, H.L. (1994). Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104-2109.
3. Bergerot, I., Fabien, N., Maguer, V., and Thivolet, C. (1994). Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7, 655-663.
4. Chen, Y., Kuchroo, V.K., Inobe, J.I., Hafler, D.A., and Weiner, H.L. (1994). Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
5. Chen, Y., Inobe, J., and Weiner, H.L. (1995). Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4+ and CD8+ cells mediate active suppression. J. Immunol. 155, 910-916.
6. Chen, Y., Inobe, J., Kuchroo, V.K., Baron, J.L., Janeway, Jr., C.A., and Weiner, H.L. (1996). Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. 93, 388-391.
7. Coon, B., An, L.L., Whitton, J.L., and Von Herrath, M.G. (1999). DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189-194.
8. Daniel, D., and Wegmann, D.R. (1996). Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 93, 956-960.
9. Gallichan, W.S., Balasa, B., Davies, J.D., and Sarvetnick, N. (1999). Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J. ImmuNol. 163, 1696-1703.
10. Garside, P., Steel, M., Liew, F.Y., and Mowat, A.M. (1995a). CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int. Immunol. 7, 501-504.
11. Garside, P., Steel, M., Worthey, E.A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F.Y., and Mowat, A.M. (1995b). T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154, 5649-5655.
12. Harrison, L.C., Dempsey-Collier, M., Kramer, D.R., and Takahashi, K. (1996). Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167-2174.
13. Herbelin, A., Gombert, J.-M., Lepault, F., Bach, J.-F., and Chatenoud, L. (1998). Mature mainstream TCRαβ+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 161, 2620-2628.
14. Homann, D., Tishon, A., Berger, D.P., Weigle, W.O., Von Herrath, M.G., and Oldstone, M.B.A. (1998). Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72, 9208-9216.
15. Homann, D., Dyrberg, T., Petersen, J., Apostolopoulos, V., Oldstone, M.b.a., and Von Herrath, M.G. (1999). Insulin in oral immune "tolerance": A one amino acid change in the B-chain makes the difference. J. Immunol. 163, 1833-1838.
16. Ihle, J.N., Thierfelder, W., Teglund, S., Stravapodis, D., Wang, D., Feng, J., and Parganas, E. (1998). Signaling by the cytokine receptor superfamily. Ann. NY Acad. Sci. 865, 1-9.
17. Inobe, J., Slavin, A.J., Komagata, Y., Chen, Y., Liu, L., and Weiner, H.L. (1998). IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 9, 2780-2790.
18. Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
19. Kapp, J.A., and Ke, Y. (1997). The role of gammadelta TCR-bearing T cells in oral tolerance. Res. Immunol. 148, 561-567.
20. Ke, Y., Pearce, K., Lake, J.P., Ziegler, H.K., and Kapp, J.A. (1997). Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158, 3610-3618.
21. Kurts, C., Kosaka, H., Carbone, F.R., Miller, J.f.a.p., and Heath, W.R. (1997). Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186, 239-245.
22. Kurts, C., Miller, J.F.A.P., Subramaniam, R.M., Carbone, F.R., and Heath, W.R. (1998). Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188, 409-414.
23. Kurts, C., Carbone, F.R., Krummel, M.F., Koch, K.M., Miller, J.F., and Heath, W.R. (1999). Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 398, 341-344.
24. Lee, M.S.,Wogensen, L., Shizuru, J., Oldstone, M.B.A., and Sarvetnick, N. (1994). Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93, 1332-1338.
25. Lider, O., Santos, L.M., Lee, C.S., Higgins, P.J., and Weiner, H.L. (1989). Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of Disease and in Vitro Immune Responses is Mediated by Antigen-specific CD8+ T Lymphocytes J. Immunol. 142, 748-752.
26. Maron, R., Palanivel, V., Weiner, H.L., and Harn, D.A. (1998). Oral administration of schistosome egg antigen and insulin B-chain generates and enhances Th2-type responses in NOD mice. Clin. Immunol. ImmuNopathol. 87, 85-92.
27. McMenamin, C., Pimm, C., McKersey, M., and Holt, P.G. (1994). Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 265, 1869-1871.
28. McMenamin, C., McKersey, M., Kuhnlein, P., Hunig, T., and Holt, P.G. (1995). Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 154, 4390-4394.
29. Mengel, J., Cardillo, F., Aroeira, L.S., Williams, O., Russo, M., and Vaz, N.M. (1995). Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48, 97-102.
30. Miller, A., Lider, O., and Weiner, H.L. (1991). Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174, 791-798.
31. Miller, A., Al-Sabbagh, A., Santos, L.M., Das, M.P., and Weiner, H.L. (1993). Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151,7307-7315.
32. Muir, A., Peck, A., Clare-Salzler, M., Song, Y.H., Cornelius, J., Luchetta, R., Krischer, J., and Maclaren, N. (1995). Insulin immunization of non-Obese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95, 628-634.
33. Nussenblatt, R.B., Caspi, R.R., Mahdi, R., Chan, C.C., Roberge, F., Lider, O., and Weiner, H.L. (1990). Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144, 1689-1695.
34. Oldstone, M.B.A., Nerenberg, M., Southern, P., Price, J., and Lewicki, H. (1991). Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 65, 319-331.
35. Polanski, M., Melican, N.S., Zhang, J., and Weiner, H.L (1997). Oral administation of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10, 339-346.
36. Sempe, P., Richard, M.F., Bach, J.F., and Boitard, C. (1994). Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37, 337-343.
37. Tada, Y., Ho, A., Koh, D.R., and Mak, T.W. (1996). Collagen-induced arthritis in CD4- Or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J. Immunol. 156, 4520-4526.
38. Vajdy, M., Kosco-Vilbois, M.H., Kopf, M., Kohler, G., and Lycke, N. (1995). Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181, 41-53.
39. Vella, A., Teague, T.K., Ihle, J., Kappler, J., and Marrack, P. (1997). Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186, 325-330.
40. Von Herrath, M.G., and Homann, D. (1997). Treatment of virus-induced autoimmune diabetes by oral administration of insulin: Study on the mechanism by which oral antigens can abrogate autoimmunity. Endocrinol. Diabetes 105, 24-25.
41. Von Herrath, M.G., and Oldstone, M.B.A. (1997). IFN-gamma is essential for b-cell destruction by CTL. J. Exp. Med. 185, 531-539.
42. Von Herrath, M.G., Dockter, J., and Oldstone, M.B.A. (1994a). How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1, 231-242.
43. Von Herrath, M.G., Dockter, J., Nerenberg, M., Gairin, J.E., and OldStone, M.B.A. (1994b). Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180, 1901-1910.
44. Von Herrath, M.G., Dyrberg, T., and Oldstone, M.B.A. (1996). Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest 98, 1324-1331.
45. Weiner, H.L. (1997). Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18, 335-343.
46. Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., Al-Sabbagh, A., Santos, L, Sayegh, M., Nussenblatt, R.B., Trentham, D.E., and Hafler, D.A. (1994). Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809-837.
47. Wildner, G., and Thurau, S.R. (1995). Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur. J. Immunol. 25, 1292-1297.
48. Yoshida, H., Hachimura, S., Hirahara, K., Hisatsune, T., Nishijima, K., Shiraishi, A., and Kaminogawa, S. (1998). Induction of oral tolerance in splenocyte-reconstituted SCID mice. Clin. Immunol. ImmuNopathol. 87, 282-291.
49. Yoshino, S., Quattrocchi, E., and Weiner, H.L. (1995). Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum. 38, 1092-1096.
50. Zhang, Z.Y., Lee, C.S., Lider, O., and Weiner, H.L. (1990). Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145, 2489-2493.